Edentree Asset Management »

Eli Lilly & Co. shares owned by Edentree Asset Management

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Edentree Asset Management from 13F filings

Historical chart of Edentree Asset Management investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Edentree Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Edentree Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $403k 750 537.02
2023-06-30 $351k 750 468.24

More positions owned by Edentree Asset Management

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Medtronic SHS (MDT)
salesforce (CRM)
Nike CL B (NKE)
Hartford Financial Services (HIG)
Analog Devices (ADI)
Valmont Industries (VMI)
Bruker Corporation (BRKR)
Boston Scientific Corporation (BSX)
Aptiv SHS (APTV)
Xylem (XYL)
Avient Corp (AVNT)
Cme (CME)
Advanced Drain Sys Inc Del (WMS)

View all positions for Edentree Asset Management

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
FMR
PRIMECAP Management Company
T. Rowe Price Associates
Jpmorgan Chase & Co
Geode Capital Management
Morgan Stanley
State Farm Mutual Automobile Insurance Company
Wellington Management Company
Bank of America Corporation
Northern Trust
Jennison Associates

View all funds holding Eli Lilly & Co.